Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Per Ljungman; Morgan Hakki; Michael Boeckh

doi:10.1016/j.hoc.2010.11.011

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Per Ljungman, Morgan Hakki, Michael Boeckh

Infectious Diseases

Research output: Contribution to journal › Review article › peer-review

288 Scopus citations

Abstract

This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.

Original language	English (US)
Pages (from-to)	151-169
Number of pages	19
Journal	Hematology/Oncology Clinics of North America
Volume	25
Issue number	1
DOIs	https://doi.org/10.1016/j.hoc.2010.11.011
State	Published - Feb 2011

Keywords

Adoptive immunotherapy
Antiviral therapy
Cytomegalovirus
Hematopoietic stem cell transplantation

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.hoc.2010.11.011

Cite this

@article{9b7b0303b1974dbb9d8733bf0b85ec72,

title = "Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients",

abstract = "This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.",

keywords = "Adoptive immunotherapy, Antiviral therapy, Cytomegalovirus, Hematopoietic stem cell transplantation",

author = "Per Ljungman and Morgan Hakki and Michael Boeckh",

note = "Funding Information: Per Ljungman had support from the Karolinska Institute research funds, the European Leukemia Net, and the Swedish Children's Cancer Fund. Michael Boeckh had support from the National Institute of Health ( NIH CA 18029 ). ",

year = "2011",

month = feb,

doi = "10.1016/j.hoc.2010.11.011",

language = "English (US)",

volume = "25",

pages = "151--169",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

AU - Ljungman, Per

AU - Hakki, Morgan

AU - Boeckh, Michael

N1 - Funding Information: Per Ljungman had support from the Karolinska Institute research funds, the European Leukemia Net, and the Swedish Children's Cancer Fund. Michael Boeckh had support from the National Institute of Health ( NIH CA 18029 ).

PY - 2011/2

Y1 - 2011/2

N2 - This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.

AB - This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.

KW - Adoptive immunotherapy

KW - Antiviral therapy

KW - Cytomegalovirus

KW - Hematopoietic stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=78651106811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651106811&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2010.11.011

DO - 10.1016/j.hoc.2010.11.011

M3 - Review article

C2 - 21236396

AN - SCOPUS:78651106811

SN - 0889-8588

VL - 25

SP - 151

EP - 169

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 1

ER -

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this